{{cart_num}}
My CartCAS：13292-46-1
Molecular Formula：C43H58N4O12
Molecular Weight：822.95
Storage：Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year
Purity：HPLC≥97%
Appearance：Red Solid
Qty：
Size：
| CAS | 13292-46-1 |
| Name | Rifampicin |
| Molecular Formula | C43H58N4O12 |
| Molecular Weight | 822.95 |
| Solubility | Soluble in DMSO ≥10mg/mL |
| Purity | HPLC≥97% |
| Appearance | Red Solid |
| Storage | Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year |
| EC | EINECS 236-312-0 |
| MDL | MFCD00151389 |
| SMILES | OC(C(/C=N/N1CCN(C)CC1)=C(NC(/C(C)=C\C=C\[C@@H]([C@@H]([C@@H](C)[C@H]2O)O)C)=O)C(O)=C3C(O)=C4C)=C3C5=C4O[C@](C)(O/C=C/[C@@H]([C@H]([C@@]([C@@H]2C)([H])OC(C)=O)C)OC)C5=O |
| InChIKey | JQXXHWHPUNPDRT-WLSIYKJHSA-N |
| InChI | InChI=1S/C43H58N4O12/c1-21-12-11-13-22(2)42(55)45-33-28(20-44-47-17-15-46(9)16-18-47)37(52)30-31(38(33)53)36(51)26(6)40-32(30)41(54)43(8,59-40)57-19-14-29(56-10)23(3)39(58-27(7)48)25(5)35(50)24(4)34(21)49/h11-14,19-21,23-25,29,34-35,39,49-53H,15-18H2,1-10H3,(H,45,55)/b12-11+,19-14+,22-13-,44-20+/t21-,23+,24+,25+,29-,34-,35+,39+,43-/m0/s1 |
| PubChem CID | 135398735 |
| Target Point | Bacterial;DNA/RNA Synthesis |
| Passage | Cell Cycle;DNA Damage/DNA Repair;Anti-infection |
| Background | It is an effective broad-spectrum antibiotic with anti-influenza virus activity. |
| Biological Activity | Rifampicin是一种有效的广谱抗生素，可抵抗细菌病原体。[1-3] |
| Data Literature Source | [1]. Piriou A，et al. Fatty liver induced by high doses of rifampicin in the rat: possible relation with an inhibition of RNA polymerases in eukariotic cells. Arch Toxicol Suppl. 1979;(2):333-7. [2]. Yu J，et al. Monitoring in vivo fitness of rifampicin-resistant Staphylococcus aureus mutants in a mouse biofilm infection model. J Antimicrob Chemother. 2005 Apr;55(4):528-34. Epub 2005 Mar 2. [3]. Erokhina MV，et al. [In vitro development of rifampicin resistance in the epithelial cells]. Probl Tuberk Bolezn Legk. 2006;(8):58-61 |
| Unit | Bottle |
| Specification | 100mg 10mM*1mL in DMSO 500mg |
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Li C, et al. Biomater Res. 2023 Apr 15;27(1):30.
Li C, et al. Biomater Res. 2023 Apr 15;27(1):30.
Sorry, there is no more information.
Modifications of Ganoderma lucidum spores into digestive-tissue highly adherent porous carriers with selective affinity to hydrophilic or hydrophobic drugs
Click to check >>Author：Ning Liao, Bing Pang, Han Jin, Xixi Zhao, Dongyan Shao, Chunmei Jiang, Junling Shi
IF：15.3040
Publish_to：BIOMATERIALS
PMID：37262935
Engineering of the DNA replication and repair machinery to develop binary mutators for rapid genome evolution of?Corynebacterium glutamicum
Click to check >>Author：Cai Ningyun, Chen Jiuzhou, Gao Ning, Ni Xiaomeng, Lei Yu, Pu Wei, Wang Lixian, Che Bin, Fan Liwen, Zhou Wenjuan, Feng Jinhui, Wang Yu, Zheng Ping, Sun Jibin
IF：14.9000
Publish_to：NUCLEIC ACIDS RESEARCH
PMID：37449409
Neutrophil-inspired photothermo-responsive drug delivery system for targeted treatment of bacterial infection and endotoxins neutralization
Click to check >>Author：Li C; Gan Y; Li Z; Fu M; Li Y; Peng X; Yang Y; Tia
IF：11.3000
Publish_to：Biomater Res
PMID：37061741
Amino acid permease RcAAP1 increases the uptake and phloem translocation of an L-valine-phenazine-1-carboxylic acid conjugate
Click to check >>Author：Xiao Y; Hu C; Hsiang T; Li J
IF：5.6000
Publish_to：Front Plant Sci
PMID：37332709
The Mycobacterium tuberculosis CRISPR-Associated Cas4 Involves Persistence and Tolerance to Anti-Tubercular Drugs
Click to check >>Author：Wei J, Lu N, Li Z, Wu X, Jiang T, Xu L, Yang C, Gu
IF：3.0470
Publish_to：Biomed Res Int.
PMID：31061828
Berberine activates PPARδ and promotes gut microbiota-derived butyric acid to suppress hepatocellular carcinoma
Click to check >>Author：Peng Cunzhi, Chang Lili, Wang Dan, Xie Quanliang, Zheng Xingmei, Xu Bingqiang, Tong Zheng
IF：2.6000
Publish_to：IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-PLANT
PMID：
Manual Download
